| Literature DB >> 12093733 |
Luciana B Chiarini1, Adriana R O Freitas, Silvio M Zanata, Ricardo R Brentani, Vilma R Martins, Rafael Linden.
Abstract
To test for a role for the cellular prion protein (PrP(c)) in cell death, we used a PrP(c)-binding peptide. Retinal explants from neonatal rats or mice were kept in vitro for 24 h, and anisomycin (ANI) was used to induce apoptosis. The peptide activated both cAMP/protein kinase A (PKA) and Erk pathways, and partially prevented cell death induced by ANI in explants from wild-type rodents, but not from PrP(c)-null mice. Neuroprotection was abolished by treatment with phosphatidylinositol-specific phospholipase C, with human peptide 106-126, with certain antibodies to PrP(c) or with a PKA inhibitor, but not with a MEK/Erk inhibitor. In contrast, antibodies to PrP(c) that increased cAMP also induced neuroprotection. Thus, engagement of PrP(c) transduces neuroprotective signals through a cAMP/PKA-dependent pathway. PrP(c) may function as a trophic receptor, the activation of which leads to a neuroprotective state.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12093733 PMCID: PMC125390 DOI: 10.1093/emboj/cdf324
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598